ASTERDMNSEAster DM Healthcare Limited· Healthcare ServicesHighNeutral
Announced Tue, 23 Jun, 2026 · 19:33 IST

Subsidiary Sarjapur allots CCPS to investors, more capital raise planned

ASTERDM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹769.65
prior close
₹769.70
announcement price
After-mkt
timing
Nifty Smallcap 250market+0.2%-0.2% vs market
Hospital peers, median of 23sector+0.8%-0.8% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Smallcap 250 and 0.8 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.4
10m
+1.1
15m
+0.4
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+0.2-0.2+0.8-0.8
Next day
-0.1-0.2+0.2-0.1+0.1
2d
-0.9-0.7-0.1-0.1-0.8
3d
+1.9-0.2+2.1+1.6+0.3
4d
+0.8+0.3+0.5+1.7-0.9
5d
+2.7+1.3+1.3+2.1+0.5
1w
+2.5+1.9+0.6+1.1+1.4
15d
+5.3+2.0+3.3+1.9+3.4
1m
+2.5-0.8+3.3+0.6+1.9
2m
-2.4+3.5-6.0-0.7-1.7
3m
-0.7+2.3-3.0-0.2-0.5
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aster DM's subsidiary, Aster DM Super-Specialty Hospital Sarjapur, allotted 12 lakh fully paid-up Series A CCPS and 34.3 lakh partly paid-up Series B CCPS at Rs 50 face value to certain identified investors on a preferential basis via private placement. Each CCPS can convert into up to 5 equity shares. The subsidiary is also finalising more investors for additional CCPS issuance. Aster DM will retain over 75 percent shareholding on an as-if converted basis.

Likely market impact

Growth capital raised at subsidiary level. Parent Aster DM keeps majority control above 75 percent, limiting any major dilution risk at the listed entity for now.